Press Releases

Our latest press releases are
available to read here

Press Releases

Date Range

Explore

Search

Press Releases / 09 Mar 2023

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022

Press Releases / 03 Mar 2023

Summit Therapeutics Closes Fully-Subscribed $500 Million Rights Offering

Press Releases / 23 Feb 2023

Summit Therapeutics’ Rights Offering Nearing Expiration Date

Press Releases / 30 Jan 2023

Summit Therapeutics Announces Timing of Rights Offering for Up to $500 Million

Press Releases / 20 Jan 2023

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Press Releases / 05 Jan 2023

Summit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Press Releases / 06 Dec 2022

Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody

Press Releases / 17 Nov 2022

Summit Therapeutics Appoints Experienced Clinical Leader Dr. Alessandra Cesano to its Board of Directors

Press Releases / 09 Nov 2022

Summit Therapeutics Inc. Reports Financial Results and Operational Progress
for the Third Quarter and Nine Months Ended September 30, 2022

Press Releases / 20 Oct 2022

Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022

Press Releases / 13 Oct 2022

Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022

Press Releases / 03 Oct 2022

Summit Therapeutics Appoints Dr. Robert Booth, Renowned Executive and Scientific Leader, to its Board of Directors

1 2 … 31 32 >>

Website Cookies

This website uses cookies: Please see our Privacy Policy to understand how we use cookies.